ETHYOL

LOE Approaching

amifostine

NDAINJECTIONINJECTABLEPriority Review
Approved
Dec 1995
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3

Clinical Trials (3)

NCT00601198Phase 2Terminated

A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer

Started Oct 2006
4 enrolled
Colorectal Cancer
NCT00095927Phase 2Completed

Randomized Amifostine For SCCHN

Started May 2003
58 enrolled
Chemotherapeutic Agent ToxicityHead and Neck CancerMucositis+2 more
NCT00003123Phase 2Unknown

Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome

Started Aug 1997
36 enrolled
Myelodysplastic Syndromes
External Resources
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers